These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 21914841)
1. How can 1 + 1 = 3? β2-adrenergic and glucocorticoid receptor agonist synergism in obstructive airway diseases. Schmidt M; Michel MC Mol Pharmacol; 2011 Dec; 80(6):955-8. PubMed ID: 21914841 [TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase-γ inhibition by long-acting β2 adrenergic agonists reversed steroid insensitivity in severe asthma. Mercado N; To Y; Kobayashi Y; Adcock IM; Barnes PJ; Ito K Mol Pharmacol; 2011 Dec; 80(6):1128-35. PubMed ID: 21917909 [TBL] [Abstract][Full Text] [Related]
3. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases. Sin DD; Man SF Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807 [TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory activities of beta2-agonists. Hanania NA; Moore RH Curr Drug Targets Inflamm Allergy; 2004 Sep; 3(3):271-7. PubMed ID: 15379595 [TBL] [Abstract][Full Text] [Related]
5. Research and development of bronchodilators for asthma and COPD with a focus on G protein/KCa channel linkage and β2-adrenergic intrinsic efficacy. Kume H; Fukunaga K; Oguma T Pharmacol Ther; 2015 Dec; 156():75-89. PubMed ID: 26432616 [TBL] [Abstract][Full Text] [Related]
6. Airway smooth muscle as a target of glucocorticoid action in the treatment of asthma. Hirst SJ; Lee TH Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 3):S201-6. PubMed ID: 9817746 [TBL] [Abstract][Full Text] [Related]
7. β2-Adrenoceptor Function in Asthma. Amrani Y; Bradding P Adv Immunol; 2017; 136():1-28. PubMed ID: 28950943 [TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled corticosteroids, leukotriene receptor antagonists, or both, plus long-acting beta2-agonists on asthma pathophysiology: a review of the evidence. Vignola AM Drugs; 2003; 63 Suppl 2():35-51. PubMed ID: 14984079 [TBL] [Abstract][Full Text] [Related]
9. Interactions between corticosteroids and beta2-agonists in asthma and chronic obstructive pulmonary disease. Johnson M Proc Am Thorac Soc; 2004; 1(3):200-6. PubMed ID: 16113435 [TBL] [Abstract][Full Text] [Related]
10. Effect of Sphingosine 1-Phosphate on Cyclo-Oxygenase-2 Expression, Prostaglandin E2 Secretion, and β2-Adrenergic Receptor Desensitization. Rumzhum NN; Rahman MM; Oliver BG; Ammit AJ Am J Respir Cell Mol Biol; 2016 Jan; 54(1):128-35. PubMed ID: 26098693 [TBL] [Abstract][Full Text] [Related]
11. Asthma pharmacotherapy. Schofield ML Otolaryngol Clin North Am; 2014 Feb; 47(1):55-64. PubMed ID: 24286679 [TBL] [Abstract][Full Text] [Related]
12. Benefit-risk assessment of long-acting beta2-agonists in asthma. Jackson CM; Lipworth B Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036 [TBL] [Abstract][Full Text] [Related]
13. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy. Hozawa S; Terada M; Haruta Y; Hozawa M Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307 [TBL] [Abstract][Full Text] [Related]
14. Triple inhalers for obstructive airways disease: will they be useful? Barnes PJ Expert Rev Respir Med; 2011 Jun; 5(3):297-300. PubMed ID: 21702649 [No Abstract] [Full Text] [Related]
15. Tiotropium improves lung function, exacerbation rate, and asthma control, independent of baseline characteristics including age, degree of airway obstruction, and allergic status. Kerstjens HA; Moroni-Zentgraf P; Tashkin DP; Dahl R; Paggiaro P; Vandewalker M; Schmidt H; Engel M; Bateman ED Respir Med; 2016 Aug; 117():198-206. PubMed ID: 27492532 [TBL] [Abstract][Full Text] [Related]
17. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659 [TBL] [Abstract][Full Text] [Related]
18. Interaction between glucocorticoids and beta2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling. Roth M; Johnson PR; Rüdiger JJ; King GG; Ge Q; Burgess JK; Anderson G; Tamm M; Black JL Lancet; 2002 Oct; 360(9342):1293-9. PubMed ID: 12414205 [TBL] [Abstract][Full Text] [Related]
19. Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE(2)SPOND). A Randomized Clinical Trial. Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Anzueto A; Alagappan VK; Siddiqui S; Rekeda L; Miller CJ; Zetterstrand S; Reisner C; Rennard SI Am J Respir Crit Care Med; 2016 Sep; 194(5):559-67. PubMed ID: 27585384 [TBL] [Abstract][Full Text] [Related]
20. Induction of regulator of G-protein signaling 2 expression by long-acting β2-adrenoceptor agonists and glucocorticoids in human airway epithelial cells. Holden NS; George T; Rider CF; Chandrasekhar A; Shah S; Kaur M; Johnson M; Siderovski DP; Leigh R; Giembycz MA; Newton R J Pharmacol Exp Ther; 2014 Jan; 348(1):12-24. PubMed ID: 24163441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]